BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12239111)

  • 21. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I; Kalamatianos T; Piggins HD; Coen CW
    J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force.
    Hinkle RT; Donnelly E; Cody DB; Sheldon RJ; Isfort RJ
    J Appl Physiol (1985); 2005 Feb; 98(2):655-62. PubMed ID: 15649881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
    Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
    Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duplicated receptors for VIP and PACAP (VPAC1R and PAC1R) in a teleost fish, Fugu rubripes.
    Cardoso JC; Power DM; Elgar G; Clark MS
    J Mol Endocrinol; 2004 Oct; 33(2):411-28. PubMed ID: 15525598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.
    Cardoso JC; Vieira FA; Gomes AS; Power DM
    Peptides; 2007 Sep; 28(9):1902-19. PubMed ID: 17826180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide: effects on insulin release in isolated mouse islets in relation to metabolic status and age.
    Persson-Sjögren S; Forsgren S; Lindström P
    Neuropeptides; 2006 Aug; 40(4):283-90. PubMed ID: 16797701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.
    Erdling A; Sheykhzade M; Maddahi A; Bari F; Edvinsson L
    Neuropeptides; 2013 Apr; 47(2):85-92. PubMed ID: 23375386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis.
    Miotto D; Boschetto P; Bononi I; Zeni E; Cavallesco G; Fabbri LM; Mapp CE
    Eur Respir J; 2004 Dec; 24(6):958-63. PubMed ID: 15572539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide.
    Voice JK; Dorsam G; Chan RC; Grinninger C; Kong Y; Goetzl EJ
    Regul Pept; 2002 Nov; 109(1-3):199-208. PubMed ID: 12409234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death.
    Niewiadomski P; Coûté-Monvoisin AC; Abad C; Ngo D; Menezes A; Waschek JA
    J Mol Neurosci; 2008 Nov; 36(1-3):200-7. PubMed ID: 18491042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor.
    Solés-Tarrés I; Cabezas-Llobet N; Lefranc B; Leprince J; Alberch J; Vaudry D; Xifró X
    Front Pharmacol; 2021; 12():797541. PubMed ID: 35153755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PACAP and VIP Neuropeptides' and Receptors' Effects on Appetite, Satiety and Metabolism.
    Vu JP; Luong L; Sanford D; Oh S; Kuc A; Pisegna R; Lewis M; Pisegna JR; Germano PM
    Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.